Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/40591917-4dea-4a67-ae03-5d3f06317bb3/

HYPR

Hyperfine Inc
Chart
$1.38
Latest Week 2026-06-05
HealthcareMedical DevicesMICRO
Snapshot 2026-06-07 · 0.0w · Fresh
0.2
OS Score
21.0%
Value
8.0%
Quality
90.0%
Momentum
4/9
F-Score
0.130
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.35
V
Value Analysis
Cheapness relative to fundamentals
21.0%ile
P/S
8.8×
P/B
3.9×
FCF Yield
-0.250
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
79.00000000
/100 — 1=cheapest
VC2 (Trending Value)
82.00000000
/100
VC3 (Buyback)
82.00000000
/100
Negative FCF yield (-25.0%) — the business is currently cash-consumptive. VC2 score of 82.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
8.0%ile
ROE
-1.012
ROA
-0.576
Net Margin
-2.269
Op Margin
-2.379
GPA
0.130
D/E
0.76
Current
5.52
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.307
Stability
0.170
lower=better
Accruals
-0.117
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
90.0%ile
6M Return
27.8%
12M Return
73.3%
12-1 Mom
112.3%
Risk-Adj
1.35
Vol 252d
82.9%
Vol 60d
181.4%
↑ Expanding
Max DD 12M
-44.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 112% is very strong — a clear uptrend. Near-term vol (181%) is expanding vs long-term (83%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.2
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
6.4%
Sector Quality %ile
2.2%
P/B z-score
-0.09
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Hot but Volatile
Strong momentum (90th) but high volatility (83%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (181%) significantly exceeds 252-day (83%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
26.9% avg (4 factors)
Quality
D
38.4% avg (8 factors)
Momentum
A
82.8% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.200—1—
Value %ile0.210—1—
Quality %ile0.080—1—
Momentum %ile0.900—1—
F-Score4.000—1—
Confidence0.848—1—
Volatility0.829—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
8.80
Price / Book
3.92
FCF Yield
-25.0%
Sales Yield (1/P·S)
0.1430
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-101.2%
Return on Assets
-57.6%
Net Margin
-226.9%
Operating Margin
-237.9%
Gross Profit / Assets
Novy-Marx GPA
13.0%
Debt / Equity
0.76
Current Ratio
5.52
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.117
MomentumPrice trend strength over different horizons
6M Return
27.8%
12M Return
73.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
112.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.35
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
30.7%
Earnings Stability (CV)
Lower = more stable
0.170
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
79
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
82
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
82
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity